SCHEMBL21452646

SCHEMBL21452646

CCCOc1ccn(C(C)C)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.36
LMNA P02545 2/20 0.33
MAPT P10636 2/20 0.33
HTT P42858 2/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22943237 0.81 DYRK1A (0.34) DYRK1AHDAC1HDAC6
SCHEMBL22943529 0.80 DYRK1A (0.33) DYRK1AHDAC1HDAC6
SCHEMBL26382784 0.80 LMNA (0.31) LMNAMAPTHTTTSHRSMN1; SMN2
SCHEMBL21468722 0.80 DYRK1A (0.37) DYRK1AHDAC1HDAC6
SCHEMBL20759271 0.80 DYRK1A (0.37) DYRK1ALMNAMAPTHTTTSHR
SCHEMBL22943015 0.77 DYRK1A (0.36) DYRK1AHDAC1HDAC6
SCHEMBL17658980 0.77 NUDT1 (0.40) DYRK1AHDAC1HDAC6GABRPGABRD
SCHEMBL23009960 0.77 NFE2L2 (0.40) SIGMAR1
SCHEMBL28149986 0.76 HDAC1 (0.40) DYRK1AMAPTSMN1; SMN2HDAC1HDAC6
SCHEMBL21165960 0.75 DYRK1A (0.38) DYRK1AHDAC1HDAC6MPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019200246-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR ABELA ALEXANDER RUSSELL (US) 2019-10-17 WO disclosed
WO-2019195739-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR ABELA ALEXANDER RUSSELL (US) 2019-10-10 WO disclosed